Genetic Variation Is Associated With C-Reactive Protein Levels in the Third National Health and Nutrition Examination Survey
- 5 December 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 114 (23) , 2458-2465
- https://doi.org/10.1161/circulationaha.106.615740
Abstract
Background— Increased serum C-reactive protein (CRP) is an independent risk factor for cardiovascular disease. Previous studies have suggested that genetic variation within the CRP gene is associated with serum CRP. Methods and Results— We genotyped CRP genetic variants in 7159 individuals from the Third National Health and Nutrition Examination Survey (NHANES III). NHANES III is American population-based sample linked to hundreds of phenotypes, including CRP; however, the CRP assay used in this survey is not a high-sensitivity CRP assay, and 65% of participants (n=4679) had CRP measurements at or below the level of detection. Despite these limitations, we identified specific CRP single-nucleotide polymorphisms (SNPs) and haplotypes associated with serum CRP levels in the general population. Two variants were associated with increased levels of serum CRP: SNP rs3093058 (in linkage disequilibrium with a CRP promoter SNP rs3093062) in the non-Hispanic black sample and the triallelic promoter SNP rs3091244 in the non-Hispanic black and Mexican American samples. Two other SNPs were associated with decreased levels of serum CRP in either the non-Hispanic black (rs1205 and rs2808630) or Mexican American (rs1205) samples. Three haplotypes inferred from 7 SNPs (ATTGCGA, TTAGCGA, and AAAGAGA) were associated ( P ≤0.01) with increased levels of serum CRP in the non-Hispanic black sample; 2 haplotypes (ATTGCGA and AAAGCGA) were associated ( P P Conclusions— Genetic variation within CRP is associated with serum CRP levels in the general population and may be associated with prevalent coronary heart disease.Keywords
This publication has 50 references indexed in Scilit:
- Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- GENETICS OF ATHEROSCLEROSISAnnual Review of Genomics and Human Genetics, 2004
- C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart DiseaseNew England Journal of Medicine, 2004
- The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and strokeNature Genetics, 2004
- Functional SNPs in the lymphotoxin-α gene that are associated with susceptibility to myocardial infarctionNature Genetics, 2002
- Replication validity of genetic association studiesNature Genetics, 2001
- Novel Risk Factors for Systemic AtherosclerosisJAMA, 2001
- Association study designs for complex diseasesNature Reviews Genetics, 2001
- Chlamydia pneumoniae infection and mortality from ischaemic heart disease: large prospective studyBMJ, 2000
- Coronary heart disease:: At the interface of molecular genetics and preventive medicineAmerican Journal of Preventive Medicine, 1999